A
Anhui Fengyuan Pharmaceutical Co Ltd
SZSE:000153
Anhui Fengyuan Pharmaceutical Co Ltd
SZSE:000153
Price:
6.71
CNY
2.44%
Market Closed
Market Cap:
¥3.1B
Relative Value
The Relative Value of one Anhui Fengyuan Pharmaceutical Co Ltd stock under the Base Case scenario is 9.44 CNY. Compared to the current market price of 6.71 CNY, Anhui Fengyuan Pharmaceutical Co Ltd is Undervalued by 29%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
9.44
CNY
Undervaluation 29%
A
Multiples Across Competitors
Competitors Multiples
Anhui Fengyuan Pharmaceutical Co Ltd Competitors
Anhui Fengyuan Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
A
|
Anhui Fengyuan Pharmaceutical Co Ltd
SZSE:000153
|
3.1B CNY | 0.8 | 27.4 | 23.8 | 23.8 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
976.4B USD | 15 | 47.3 | 31.9 | 33.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
590.4B USD | 6.3 | 22 | 15.3 | 18.8 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
294.6B CHF | 4.8 | 31.3 | 13.2 | 15.4 | |
| CH |
|
Novartis AG
SIX:NOVN
|
248.5B CHF | 5.7 | 22.9 | 14.1 | 18.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236B GBP | 5.4 | 31.1 | 17.2 | 24.2 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
306.5B USD | 4.7 | 16.8 | 10.5 | 12.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.5 | 10.4 | 7.7 | 9.1 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.2B USD | 2.5 | 19.8 | 7.4 | 9.9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123.7B USD | 2.6 | 17.5 | 7.3 | 9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
